AdaptHealth Corp. (AHCO) stock
AHCONasdaqServices-Home Health Care ServicesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 6/3042% below fair value
$7.37−0.16 (-2.12%)
Close on Nov 18, 2026Market cap $1.00BP/E –Yield –
AdaptHealth revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
AdaptHealth's revenue for the twelve months ending Jun 30, 2026 was $3.23B, up 4.2% year over year. For fiscal 2025 it was $3.24B, down 0.5% from the year before. The highest annual figure on record is $3.26B in fiscal 2024.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.24B | -0.5% |
| FY2024 | Dec 31, 2024 | $3.26B | +1.9% |
| FY2023 | Dec 31, 2023 | $3.20B | +7.7% |
| FY2022 | Dec 31, 2022 | $2.97B | +21.0% |
| FY2021 | Dec 31, 2021 | $2.45B | +132.4% |
| FY2020 | Dec 31, 2020 | $1.06B | +99.5% |
| FY2019 | Dec 31, 2019 | $529.64M | +53.4% |
| FY2018 | Dec 31, 2018 | $345.28M | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $740.31M | +12.7% |
| Q1 FY2026 | Mar 31, 2026 | $819.80M | +5.4% |
| Q4 FY2025 | Dec 31, 2025 | $846.29M | -1.2% |
| Q3 FY2025 | Sep 30, 2025 | $820.31M | +1.8% |
| Q2 FY2025 | Jun 30, 2025 | $657.10M | -18.5% |
| Q1 FY2025 | Mar 31, 2025 | $777.88M | -1.8% |
| Q4 FY2024 | Dec 31, 2024 | $856.65M | -0.2% |
| Q3 FY2024 | Sep 30, 2024 | $805.86M | +0.2% |
| Q2 FY2024 | Jun 30, 2024 | $805.98M | +1.6% |
| Q1 FY2024 | Mar 31, 2024 | $792.50M | +6.4% |
| Q4 FY2023 | Dec 31, 2023 | $858.23M | +10.0% |
| Q3 FY2023 | Sep 30, 2023 | $804.03M | +6.3% |
| Q2 FY2023 | Jun 30, 2023 | $793.29M | +9.0% |
| Q1 FY2023 | Mar 31, 2023 | $744.63M | +5.4% |
| Q4 FY2022 | Dec 31, 2022 | $780.28M | +11.1% |
| Q3 FY2022 | Sep 30, 2022 | $756.50M | +15.8% |
| Q2 FY2022 | Jun 30, 2022 | $727.61M | +17.9% |
| Q1 FY2022 | Mar 31, 2022 | $706.20M | +46.5% |
| Q4 FY2021 | Dec 31, 2021 | $702.11M | +101.5% |
| Q3 FY2021 | Sep 30, 2021 | $653.29M | +129.7% |
| Q2 FY2021 | Jun 30, 2021 | $617.02M | +165.8% |
| Q1 FY2021 | Mar 31, 2021 | $482.12M | +151.8% |
| Q4 FY2020 | Dec 31, 2020 | $348.43M | +133.0% |
| Q3 FY2020 | Sep 30, 2020 | $284.41M | +108.4% |
| Q2 FY2020 | Jun 30, 2020 | $232.12M | +87.0% |
| Q1 FY2020 | Mar 31, 2020 | $191.44M | +60.2% |
| Q4 FY2019 | Dec 31, 2019 | $149.54M | – |
| Q3 FY2019 | Sep 30, 2019 | $136.45M | – |
| Q2 FY2019 | Jun 30, 2019 | $124.15M | – |
| Q1 FY2019 | Mar 31, 2019 | $119.50M | – |
See a number that looks wrong?